Cover
Vol. 15 No. 1 (2025)

Published: June 30, 2025

Pages: 35-59

Articles

The Body Mass Index Impaction on the Intra-cytoplasmic Sperm injection Outcomes in PCOS and non PCOS infertile Iraqi Women Using Antagonist Protocol

Inaam Khazal S. Al-Zori 1 Muayad Sraibet Abood Hayder A. L. Mossa
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq.
History
  • Received: January 7, 2025
  • Accepted: March 30, 2025
  • Available Online: June 8, 2025
DOI

https://doi.org/10.28969/IJEIR.v15.i1.r4.25

Abstract

Obesity induces metabolic dysfunctions in bodily systems and is a significant health challenge. Excessive adipose tissue accumulation encompasses dynamic, endocrine, and biologically active processes. The fundamental pathogenic mechanism of obesity is chronic low-grade inflammation exacerbated by pro-inflammatory biomarkers such as free fatty acids, lipopolysaccharides, adipokines, and cytokines. The rising prevalence of obesity over the past forty years has led to an increase in associated comorbidities, including polycystic ovarian syndrome (PCOS). To clarify the impact of increasing body mass index (BMI) in PCOS and non PCOS on the ICSI outcomes of 143 infertile Iraqi females, dividing them into two main groups: PCOS and non PCOS and each group into normal weight and overweight/obese group. Group 1= normal BMI PCOS, group 2= overweight/ obese PCOS, group 3= normal BMI non PCOS, group 4= overweight/obese non PCOS. Significant differences in ICSI outcomes were observed in the PCOS groups compared to the non-PCOS groups concerning the total number of harvested, MI, MII oocytes, GV, abnormal and fertilised oocytes, total and D3 grade I embryos alongside higher number of arrested and transplanted embryos. There are numerically higher number of D3 grade II and III embryos, morula and blastocyst with no significant difference seen. The rates of maturation and fertilisation exhibited no significant disparities. The biochemical pregnancy rate was higher in group 2 compared to group 1, and in group 4 compared to group 3, with a statistically significant difference. A higher BMI among younger PCOS individuals may be associated with better pregnancy outcomes.

Keywords

References

  1. Raaf, G.B., Mohammed, A.A. and Jawad, M.A., 2022. The comparison of the effect of recombinant FSH in antagonist protocol on serum and follicular fluid Kisspeptin between PCOS and non-PCOS infertile women during ICSI. Int J Drug Deliv Technol, 12, pp.33-38.
  2. Jayawardena, R., Ranasinghe, P., Ranathunga, T., Mathangasinghe, Y., Wasalathanththri, S. and Hills, A.P., 2020. Novel anthropometric parameters to define obesity and obesity-related disease in adults: a systematic review. Nutrition Reviews, 78(6), pp.498-513.
  3. Chooi, Y.C., Ding, C. and Magkos, F., 2019. The epidemiology of obesity. Metabolism, 92, pp.6-10.
  4. Dawood, S.A., Mossa, H.A.L. and Jwad, M.A., 2024. Influence of Obesity and Insulin Resistance on the Reproductive Outcome of Iraqi Women Undergoing Intracytoplasmic Sperm Injection. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219), 6(1), pp.179-187.
  5. Gambineri, A., Laudisio, D., Marocco, C., Radellini, S., Colao, A., Savastano, S. and Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group, 2019. Female infertility: which role for obesity?. International journal of obesity supplements, 9(1), pp.65-72.
  6. Slopien, R., Horst, N., Jaremek, J.D., Chinniah, D. and Spaczynski, R., 2019. The impact of surgical treatment of obesity on the female fertility. Gynecological Endocrinology, 35(2), pp.100-102.
  7. Hussein Mohsin, H.A., Jwad, M.A. and Mossa, H.A., 2023. Is There a Correlation between Serum SFRP5 and Wnt5a Proteins and Insulin Resistance in Iraqi Infertile Females Undergoing ICSI?. Al-Anbar Medical Journal, 19(2).
  8. Amiri, M. and Tehrani, F.R., 2020. Potential adverse effects of female and male obesity on fertility: a narrative review. International journal of endocrinology and metabolism, 18(3), p.e101776.
  9. Chen, W, Pang, Y, Hill, JW & Meikle, P 2021, ‘Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites’, Metabolites 2021, Vol. 11, Page 869, vol. 11, no. 12, p. 869.
  10. Christ, J.P. and Cedars, M.I., 2023. Current guidelines for diagnosing PCOS. Diagnostics, 13(6), p.1113.
  11. Teede, H.J., Mousa, A., Tay, C.T., Costello, M.F., Brennan, L., Norman, R.J., Pena, A.S., Boyle, J.A., Joham, A., Berry, L. and Moran, L., 2024. Summary of the 2023 international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective. Medical Journal of Australia, 221(7), pp.389- 395.
  12. Gorsic, L.K., Kosova, G., Werstein, B., Sisk, R., Legro, R.S., Hayes, M.G., Teixeira, J.M., Dunaif, A. and Urbanek, M., 2017. Pathogenic anti-Müllerian hormone variants in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 102(8), pp.2862-2872.
  13. Day, F., Karaderi, T., Jones, M.R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L. and Magi, R., 2018. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS genetics, 14(12), p.e1007813.
  14. Gorsic , L.K., Dapas, M., Legro, R.S., Hayes, M.G. and Urbanek, M., 2019. Functional genetic variation in the anti- Müllerian hormone pathway in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 104(7), pp.2855-2874.
  15. Ribeiro, LM, Sasaki, LMP, Silva, AA, Souza, ES, Oliveira Lyrio, A, C.M.G. Figueiredo, A & Gottems, LBD 2022, ‘Overweight, obesity and assisted reproduction: A systematic review and meta- analysis’, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 271, pp. 117–127.
  16. Wang, R. and Mol, B.W.J., 2017. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Human Reproduction, 32(2), pp.261-264.
  17. Boitrelle, F., Shah, R., Saleh, R., Henkel, R., Kandil, H., Chung, E., Vogiatzi, P., Zini, A., Arafa, M. and Agarwal, A., 2021. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life, 11(12), p.1368.
  18. Arabipoor, A., Ashrafi, M., Hemat, M. and Zolfaghari, Z., 2019. The effects of maternal and paternal body mass index on live birth rate after intracytoplasmic sperm injection cycles. International journal of fertility &sterility, 13(1), p.24.
  19. Andreacchi, A.T., Griffith, L.E., Guindon, G.E., Mayhew, A., Bassim, C., Pigeyre, M., Stranges, S. and Anderson, L.N., 2021. Body mass index, waist circumference, waist-to-hip ratio, and body fat in relation to health care use in the Canadian Longitudinal Study on Aging. International Journal of Obesity, 45(3), pp.666-676.
  20. Al Hourani, H., Alkhatib, B. and Abdullah, M., 2022. Impact of COVID-19 lockdown on body weight, eating habits, and physical activity of Jordanian children and adolescents. Disaster medicine and public health preparedness, 16(5), pp.1855-1863.
  21. Armanini, D., Boscaro, M., Bordin, L. and Sabbadin, C., 2022. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. International journal of molecular sciences, 23(8), p.4110.
  22. Al-Obaidi, M.T., Mahdi, H.B. and Alwasiti, E., 2018. The impact of age and BMI on oocyte maturation and embryo development. Biomedical Research, 29(9), pp.1920-1924.
  23. Yilmaz, F, Sürücüoğlu, MS & Çağiran, FT 2017, ‘Association of Obesity with Primary and Secondary Infertility among Infertile Women in Turkey: A Cross-sectional Study’, Journal of Food and Nutrition Research, vol. 5, no. 4, pp. 208–213.
  24. Mahesan, A.M., Sadek, S., Moussavi, V., Vazifedan, T., Majeed, A., Cunningham, T., Oehninger, S. and Bocca, S., 2018. Clinical outcomes following ICSI cycles using surgically recovered sperm and the impact of maternal age: 2004–2015 SART CORS registry. Journal of AssistedReproduction and Genetics, 35, pp.1239-1246.
  25. McPherson, N.O., Zander-Fox, D., Vincent, A.D. and Lane, M., 2018. Combined advanced parental age has an additive negative effect on live birth rates—data from 4057 first IVF/ICSI cycles. Journal of assisted reproduction and genetics, 35, pp.279-287.
  26. Peuranpää, P., Hautamäki, H., Halttunen- Nieminen, M., Hydén-Granskog,C. and Tiitinen, A.J.H.R., 2020. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment. Human Reproduction, 35(3), pp.504-515.
  27. Ribeiro, S. and Sousa, M., 2023. In Vitro Fertilisation and Intracytoplasmic Sperm Injection predictive factors: A review of the effect of female age, ovarian reserve, male age, and male factor on IVF/ICSI treatment outcomes. JBRA assisted reproduction, 27(1), p.97.
  28. Tan, T.Y., Lau, M.S.K., Loh, S.F. and Tan, H.H., 2014. Female ageing and reproductive outcome in assisted reproduction cycles. Singapore medical journal, 55(6), p.305.
  29. Bilibio, J.P., Lorenzzoni, P.L., Meireles, A.J.C., Maciel, Y., Sales, P. and do Nascimento, F.C., 2021. The usefulness of metaphase I oocytes in women who undergo controlled ovarian hyperstimulation for intracytoplasmic sperm injection. JBRA Assisted Reproduction, 25(1), p.115.
  30. Li, YH, Li, HR & Wang, PH 2019, ‘Parameters to predict the pregnancy in assisted reproductive technology’, Journal of the Chinese Medical Association, vol. 82, no. 4, pp. 249–250.
  31. Londero, AP, Rossetti, E, Pittini, C, Cagnacci, A & Driul, L 2019, ‘Maternal age and the risk of adverse pregnancy outcomes: A retrospective cohort study’, BMC Pregnancy and Childbirth, vol. 19, no. 1, pp. 1–10.
  32. Cedars, M.I., 2022. Evaluation of female fertility—AMH and ovarian reserve testing. The Journal of Clinical Endocrinology & Metabolism, 107(6), pp.1510-1519.
  33. Cimadomo, D, Fabozzi, G, Vaiarelli, A, Ubaldi, N, Ubaldi, FM & Rienzi, L 2018, ‘Impact of maternal age on oocyte and embryo competence’, Frontiers in Endocrinology, vol. 9, no. JUL.
  34. Zhang, X., Bai, L., Ren, H., Liu, X., Guo, S., Xu, P., Zheng, J., Zheng, L. and Tan, J., 2021. Perinatal and maternal outcomes after frozen versus fresh embryo transfer cycles in women of advanced maternal age. European Journal of Obstetrics & Gynecology and Reproductive Biology, 257, pp.133-137.
  35. Humm, M., 2015. A readers guide to contemporary feminist literary criticism. Routledge.
  36. Abdulazeez, H., Abbood, M. and Jwad, M., 2022. Impact of Reactive Oxygen Species Level in Serum and Culture Media on Pregnancy Rate after Day 3 and Day 5 Embryo Transfer in Iraqi Infertile Females Undergoing ICSI. Iraqi Journal of Embryos and Infertility Researches, 12(2), pp.12-29.
  37. Chen, H, Li, J, Cai, S, Zeng, S, Yin, C, Kuang, W, … Hocher, B 2022, ‘Impact of body mass index (BMI) on the success rate of fresh embryo transfer in women undergoing first in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment’, International Journal of Obesity, vol. 46, no. 1, pp. 202–210.
  38. Chen, HJ, Li, Y, Li, XF, Lin, G, Lu, GX & Gong, F 2020, ‘A modified ultra-long downregulation protocol improves pregnancy outcomes in high body mass index patients undergoing in vitro fertilization/intracytoplasmic sperm injection treatment’, Reproductive and Developmental Medicine, vol. 4, no. 3, pp. 163–168.
  39. Silvestris, E, de Pergola, G, Rosania, R & Loverro, G 2018, ‘Obesity as disruptor of the female fertility’, Reproductive Biology and Endocrinology, vol. 16, no. 1, pp. 1–13.
  40. Pujol, A., García, D., Obradors, A., Rodríguez, A. and Vassena, R., 2018. Is there a relation between the time to ICSI and the reproductive outcomes?. Human Reproduction, 33(5), pp.797-806.
  41. Maggiulli, R., Cimadomo, D., Fabozzi, G., Papini, L., Dovere, L., Ubaldi, F.M. and Rienzi, L., 2020. The effect of ICSI-related procedural timings and operators on the outcome. Human Reproduction, 35(1), pp.32- 43.
  42. Wu, L., Fang, Q., Wang, M., Wang, Y., Zhu, X., Fang, Z., Lu, F., Xu, B., Jin, R., Han, H. and Tong, X., 2022. Effect of weight loss on pregnancy outcomes, neuronal- reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET. Frontiers in Endocrinology, 13, p.954428.
  43. Jabeen, F., Khadija, S. and Daud, S., 2022. Prevalence of primary and secondary infertility. Saudi Journal of Medicine, 7(1), pp.22-28.
  44. Abebe, M.S., Afework, M. and Abaynew, Y., 2020. Primary and secondary infertility in Africa: systematic review with meta-analysis. Fertility research and Practice, 6, pp.1-11.
  45. Kazemijaliseh, H, Ramezani Tehrani, F, Behboudi-Gandevani, S, Hosseinpanah, F, Khalili, D & Azizi, F 2015, ‘The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study’, Global Journal of Health Science, vol. 7, no. 6, p. 226.
  46. Bai, S, Li, Y, Hu, MH, Wu, L, Shui, LJ, Wang, XH, … Xu, B 2022, ‘Association of sexually transmitted infection with semen quality in men from couples with primary and secondary infertility’, Asian Journal of Andrology, vol. 24, no. 3, p. 317.
  47. Kollmann, M., Martins, W.P., Lima, M.L.S., Craciunas, L., Nastri, C.O., Richardson, A. and Raine‐Fenning, N., 2016. Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta‐ analysis. Ultrasound in Obstetrics & Gynecology, 48(6), pp.709-718.
  48. Yang, W., Yang, R., Yang, S., Li, J., Tu, B., Gao, C. and Wang, Y., 2018. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism. Gynecological Endocrinology, 34(8), pp.715- 718.
  49. Nikbakht, R, Mohammadjafari, R, Rajabalipour, M & Moghadam, MT 2021, ‘Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles’, Fertility Research and Practice 2021 7:1, vol. 7, no. 1, pp. 1–6
  50. Uk, A, Decanter, C, Grysole, C, Keller, L, Béhal, H, Silva, M, … Barbotin, AL 2022, ‘Polycystic ovary syndrome phenotype does not have impact on oocyte morphology’, Reproductive Biology and Endocrinology, vol. 20, no. 1, pp. 1–13.
  51. Al-Yasiry,R.Z.,Jawad,M.A. and Abbood, M.S., 2024. Association of methylenetetrahydrofolate reductase gene polymorphism C677T with oocyte number and embryo quality in Iraqi infertile women undergoing intracytoplasmic sperm injection. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219), 6(1), pp.39-45.
  52. Jassim, WH, Al-Obaidi, T, Abdulhameed, WA, Al-obaidi, MT & Abdulhameed, WA 2019, ‘The Effect of Insulin Resistance on Oocyte Maturation and Embryo Quality in PCOS Patients Undergoing ICSI’, International Journal of Pharmaceutical and Phytopharmacological Research, vol. 9, no. 1, pp. 36–43.
  53. Cena, H, Chiovato, L & Nappi, RE 2020, Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists, vol. 105, The Endocrine Society, no. 8, p. e2695, viewed 4 August 2022.
  54. Artini, P G, Malacarne, E, Tomatis, V, Genazzani, AD & Artini, Paolo Giovanni 2021, ‘The relevance of inositols treatment for PCOS before and during ART’, European Review for Medical and Pharmacological Sciences, vol. 25, pp. 4799–4809.
  55. Namita, J, Sonia, M & Ved, P 2022, ‘Impact of various PCOS phenotypes on oocyte competence in an ART cycle’, Clinical Journal of Obstetrics and Gynecology, vol. 5, no. 2, pp. 067–071.
  56. Zolton, J.R. and Torrealday, S., 2021. In vitro fertilization for polycystic ovarian syndrome. Clinical obstetrics and gynecology, 64(1), pp.39-47.
  57. Al-yasiry, R.Z., Jwad, M.A., Hasan, M.F. and Alsayigh, H.A., 2022. How obesity affects female fertility. Medical Journal of Babylon, 19(2), pp.111-114.
  58. Dornelles, VC, Hentschke, MR, Badalotti, M, Telöken, IB, Trindade, VD, Cunegatto, B, … Padoin, AV 2022, ‘The impact of body mass index on laboratory, clinical outcomes and treatment costs in assisted reproduction: a retrospective cohort study’, BMC Women’s Health, vol. 22, no. 1, pp. 1–8.
  59. Broughton, DE & Moley, KH 2017, ‘Obesity and female infertility: potential mediators of obesity’s impact’, vol. 107, no. 4, pp. 840–847.
  60. Wang, H, Zhang, Y, Fang, X, Kwak- Kim, J & Wu, L 2021, ‘Insulin Resistance Adversely Affect IVF Outcomes in Lean Women Without PCOS’, Frontiers in Endocrinology, vol. 12, no. September, pp. 1– 8.
  61. Wan, Y, Muhammad, T, Huang, T, Lv, Y, Sha, Q, Yang, S, … Liu, H 2022, ‘IGF2 reduces meiotic defects in oocytes from obese mice and improves embryonic developmental competency’, Reproductive Biology and Endocrinology, vol. 20, no. 1, pp. 1–13.
  62. Keefe, DL 2020, ‘Telomeres and genomic instability during early development’, European Journal of Medical Genetics, vol. 63, no. 2, p. 103638.
  63. Leary, C, Leese, HJ & Sturmey, RG 2015, ‘Human embryos from overweight and obese women display phenotypic and metabolic abnormalities’, Human Reproduction, vol. 30, no. 1, pp. 122–132.
  64. Comstock, I.A., Kim, S., Behr, B. and Lathi, R.B., 2015. Increased body mass index negatively impacts blastocyst formation rate in normal responders undergoing in vitro fertilization. Journal of assisted reproduction and genetics, 32, pp.1299-1304.
  65. Sermondade, N., Huberlant, S., Bourhis- Lefebvre, V., Arbo, E., Gallot, V., Colombani, M. and Fréour, T., 2019. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Human reproduction update, 25(4), pp.439-451.
  66. Liu, D., Li, L., Sun, N., Zhang, X., Yin, P., Zhang, W., Hu, P., Yan, H. and Zhang, Q., 2023. Effects of body mass index on IVF outcomes in different age groups. BMC Women's Health, 23(1), p.416.
  67. Raviv, S., Hantisteanu, S., Sharon, S.M., Atzmon, Y., Michaeli, M. and Shalom-Paz, E., 2020. Lipid droplets in granulosa cells are correlated with reduced pregnancy rates. Journal of ovarian research, 13, pp.1-10.
  68. Romanski, P.A., Bortoletto, P., Chung, A., Magaoay, B., Rosenwaks, Z. and Spandorfer, S.D., 2021. Reproductive and obstetric outcomes in mildly and significantly underweight women undergoing IVF. Reproductive BioMedicine Online, 42(2), pp.366-374.
  69. Kotlyar, A.M. and Seifer, D.B., 2023. Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes. Reproductive biology and endocrinology, 21(1), p.70.
  70. Chen, Z.J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y., Yang, J., Liu, J., Wei, D., Weng, N. and Tian, L., 2016. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 375(6), pp.523-533.
  71. Voss, K.A., Chen, Y.F.M., Castillo, D.A., Vitek, W.S. and Alur-Gupta, S., 2024. Ovulation-induced frozen embryo transfer regimens in women with polycystic ovary syndrome: a systematic review and meta- analysis. Journal of Assisted Reproduction and Genetics, 41(9), pp.2237-2251.
  72. Venetis, C.A., 2022. Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?. Human Reproduction, 37(7), pp.1379-1387. .